Clinical Briefings™: Updates in Pulmonary Sarcoidosis – Advances in Treatment and Optimal Diagnosis

Released On
October 29, 2020

Expires On
October 29, 2021

Media Type
Internet

Completion Time
60 minutes

Specialty
Pulmonology

Topic(s)
Respiratory

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

This activity is supported by an educational grant from Mallinckrodt.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This online educational activity is directed toward pulmonologists, primary care physicians, nurse practitioners, physician assistants, nurses, and additional health care professionals involved in the management of pulmonary sarcoidosis

Activity Overview

This online activity provides a concise, focused overview of clinical aspects of pulmonary sarcoidosis, including the immunopathologic underpinnings, clinical presentation, evaluation and diagnostic approach of patients suspected to have the condition, and the efficacy and safety of therapies recommended for its management. The multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the immunopathology of pulmonary sarcoidosis
  • Evaluate the efficacy and safety of therapies for patients with pulmonary sarcoidosis
  • Apply evidence-based best practices for optimal diagnosis and management of pulmonary sarcoidosis

Faculty

Robert P. Baughman, MD

Robert P. Baughman, MD

Professor of Medicine
Department of Medicine
University of Cincinnati Medical Center
Cincinnati, OH

Accreditation Statement

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

In accordance with ACCME guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Robert P. Baughman, MD

  • Grant Research Support: Mallinckrodt, Genentech, Bayer, aTyr, Actelion, Meitheal, Gilead;
  • Consultant: Mallinckrodt, Actelion, Novartis;
  • Speakers Bureau: Mallinckrodt, Boehringer Ingelheim

The staff of Physicians’ Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Complete the activity (including pre- and postactivity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.
You may immediately download your certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.